-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VitaG+qAJDchYYBS1D17zf/h4qHxMJCV4zeggTim34I9DzpQtwt7OzIut9iAZjIo AKmdGz9neVeqWdaxWtnJCg== 0000947871-02-000682.txt : 20020416 0000947871-02-000682.hdr.sgml : 20020416 ACCESSION NUMBER: 0000947871-02-000682 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020331 FILED AS OF DATE: 20020412 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DEPOMED INC CENTRAL INDEX KEY: 0001005201 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943229046 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13111 FILM NUMBER: 02608831 BUSINESS ADDRESS: STREET 1: 1360 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 6504625900 MAIL ADDRESS: STREET 1: 1360 O'BRIEN DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 COMPANY DATA: COMPANY CONFORMED NAME: ORBIMED CAPITAL LLC CENTRAL INDEX KEY: 0001157524 OWNER IRS NUMBER: 134133323 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 767 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2127396400 MAIL ADDRESS: STREET 1: 767 THIRD AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 4 1 f4_041002-capital.txt FORM 4-STATEMENT OF CHANGES IN OWNERSHIP [FORM 4] OMB APPROVAL ------------------------------- OMB Number 3235-0287 Expires: December 31, 2001 Estimated average burden hours per response ...............0.5 ------------------------------- U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 (Print or Type Responses) - -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* OrbiMed Capital LLC (1) - -------------------------------------------------------------------------------- (Last) (First) (Middle) 767 Third Avenue - -------------------------------------------------------------------------------- (Street) New York NY 10010 - -------------------------------------------------------------------------------- (City) (State) (Zip) - -------------------------------------------------------------------------------- 2. Issuer Name and Ticker or Trading Symbol Depomed, Inc. (DMI) - -------------------------------------------------------------------------------- 3. IRS or Social Security Nummber of Reporting Person (Voluntary) - -------------------------------------------------------------------------------- 4. Statement for Month/Year March 2002 - -------------------------------------------------------------------------------- 5. If Amendment, Date of Original (Month/Year) - -------------------------------------------------------------------------------- 6. Relationship of Reporting Persons to Issuer (Check all applicable) [_] Director [X] 10% Owner [_] Officer (give title below) [_] Other (specify below) - -------------------------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person ----- X Form filed by More than One Reporting Person ----- - -------------------------------------------------------------------------------
==================================================================================================================================== Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ==================================================================================================================================== 1. Title of 2. Transaction 3. Transac- 4. Securities 5. Amount of 6. Ownership 7. Nature of Security (Month/ tion Code Acquired (A) Securities Form: Indirect (Instr. 3) Day/Year) (Instr. 8) or Disposed Beneficially Direct (D)or Beneficial of (D) Owned at End Indirect (I) Ownership (Instr. 3, of Month (Instr. 4) (Instr. 4) 4 and 5) (Instr. 3 and 4) -------------- -------------------- Code V Amount (A)or Price (D) -------------- -------------------- - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock N/A N/A 2,002,300 I(3) - ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v) (Over) Page 1 of 2 Pages Page 1
==================================================================================================================================== Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ==================================================================================================================================== 1. Title of 2.Conver- 3.Trans- 4.Trans- 5. Number of Deriv- 6. Date Exer- 7. Title and Amount of Derivative sion or action action ative cisable and Underlying Securities Security Exercise Date Code Securities Expiration (Instr. 3 and 4) (Instr. 3) Price (Month/ (Instr. 8) Acquired (A) or Date of Deri- Day/ Disposed of (D) (Month/Day/ vative Year) (Instr. 3, 4 Year) Security and 5) ------------ ------------------- ---------------------------------------------- Date Expira- Amount or Exer- tion Number of Code V (A) (D) cisable Date Title Shares ------------ ------------------- ---------------------------------------------- - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock Warrant (2) 3/27/02 C 178,551 Common Stock 178,551 - ------------------------------------------------------------------------------------------------------------------------------------
==================================================================================================================================== Table II -- Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) (continued) ==================================================================================================================================== - ------------------------------------------------------------------------------------------------------------------------------------ 8. Price 9. Number of 10. Owner- 11. Nature of of Derivative ship Indirect Deriv- Securities Form Beneficial ative Beneficially of Ownership Secur- Owned at Deriva- (Instr. ity End of tive 4) (Instr. Month Se- 5) (Instr. 4) curity: Direct (D) or Indirect (I) (Instr.4) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock Warrant (2) 0 I(3) - ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
Explanation of Responses: (1) Joint filing with OrbiMed Advisors LLC, OrbiMed Capital LLC and Samuel D. Isaly (4) of the same address. (2) The securities were converted pursuant to a cashless warrant exchange. (3) OrbiMed Advisors LLC, OrbiMed Capital LLC and OrbiMed Advisers Inc. have investment management discretion over a number of colletive investment funds investing in Depomed, Inc. stock. The reporting persons have no beneficial interest in the securities pursuant to Rule 16a-1(2). (4) OrbiMed Advisors Inc. is 100% owned by Samuel D. Isaly who also has a controlling interest in OrbiMed Advisors LLC and OrbiMed Capital LLC. ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. /s/Samuel D. Isaly 4/11/02 ------------------------------ ----------- **Signature of Reporting Person Date Page 2 of 2 Pages Page2 SEC 1474 (3-99) -----END PRIVACY-ENHANCED MESSAGE-----